From bench to bedside: promising colon cancer clinical trials

Am J Manag Care. 2013 Jan-Feb;19(1 Spec No):SP32-7.
No abstract available

Publication types

  • Review

MeSH terms

  • Alanine / analogs & derivatives
  • Alanine / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use
  • Benzamides / therapeutic use
  • Cancer Vaccines
  • Clinical Trials as Topic*
  • Colorectal Neoplasms / mortality
  • Colorectal Neoplasms / pathology
  • Colorectal Neoplasms / therapy*
  • Doxorubicin / chemistry
  • Drug Combinations
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hyperthermia, Induced
  • Lapatinib
  • Liposomes / chemistry
  • Niacinamide / analogs & derivatives
  • Niacinamide / therapeutic use
  • Phenylurea Compounds / therapeutic use
  • Protein Kinase Inhibitors / therapeutic use
  • Pyridines / therapeutic use
  • Pyrrolidines
  • Quinazolines / therapeutic use
  • Ramucirumab
  • Sorafenib
  • Thymine
  • Topoisomerase I Inhibitors / therapeutic use
  • Triazines / therapeutic use
  • Trifluridine / therapeutic use
  • Uracil / analogs & derivatives
  • Uracil / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Benzamides
  • Cancer Vaccines
  • Drug Combinations
  • FANG vaccine
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Liposomes
  • Phenylurea Compounds
  • Protein Kinase Inhibitors
  • Pyridines
  • Pyrrolidines
  • Quinazolines
  • Topoisomerase I Inhibitors
  • Triazines
  • trifluridine tipiracil drug combination
  • Lapatinib
  • entinostat
  • Niacinamide
  • Uracil
  • Doxorubicin
  • Sorafenib
  • brivanib
  • Alanine
  • Thymine
  • Trifluridine